Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion type Assertion NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_head.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion description "[Pharmacological agents such as pertussis toxin B-oligomer have demonstrated HIV suppressive effects via non competitive binding of CCR5, whereas interferons or interleukin-16 (IL-16) can prevent post-entry steps in HIV expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_provenance.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion evidence source_evidence_literature NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_provenance.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion SIO_000772 11472251 NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_provenance.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion wasDerivedFrom befree-2016 NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_provenance.
- NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_assertion wasGeneratedBy ECO_0000203 NP325069.RAC2Rh2MUcfYecpvQYbnTpM67yRQjRLrTvm98EWDXxy3I130_provenance.